Deutsche Bank Shifts Novartis From Hold to Sell in Q3 Review
Photo: TokenPost
Deutsche Bank shifted its Novartis recommendation to Sell, replacing Hold, on Friday, Oct. 30, as it reviewed the Swiss drugmaker’s third-quarter 2026 results. The rating decision was part of Deutsche Bank’s review of the company’s Q3 results. Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
